Yutaka Hatanaka

24PUBLICATIONS
144CO-AUTHORS
Condensed matter characterisation technique developmentCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersGene expression (incl. microarray and other genome-wide approaches)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Aug 06, 2026
Feasibility of routine clinical liquid-based cytology for lung cancer compact panel testing.

|May 29, 2026
Feasibility study of photoimmunotherapy combination with ASP-1929 for vulvar, vaginal, and cervical cancer.

|May 22, 2026
Hokkaido phase II study of photo-immunotherapy combination with ASP-1929 for recurrent or persistent EGFR-positive vulvar, vaginal, and cervical cancers not amenable to further radiotherapy (HICARi study).

|Apr 27, 2026
Tumor-Agnostic Landscape with HER2 Amplification in Japan: Real-World Prevalence and Implications for Targeting HER2.

|Mar 28, 2026
High CD73 Expression Is Associated with Poor Prognosis in Biliary Tract Cancer Through Reduced Stromal Tumor-Infiltrating Lymphocytes.

Shoya Shiratori, Kazumichi Kawakubo, Kanako C Hatanaka

|Jan 21, 2026
HER2 Protein Overexpression, mRNA Expression, and DNA Amplification Across Solid Tumors: Comparison of Next-Generation Sequencing-Based Assays With Immunohistochemistry.

Michiko Nagamine, Takao Fujisawa, Naoya Sakamoto

Pageof 4

Frequent Collaborators

6 joint publications

Kanako C Hatanaka

3 joint publications

Kosuke Ishikawa

3 joint publications

Yoshiki Shinomiya

3 joint publications

Michiko Nagamine